Aandeel ATT ABATTIS BIOCEUTICALS CORP.
Toevoegen aan een lijst
Om deze functie te gebruiken moet u een klant of lid zijn.
InloggenRegistreren
Inactief instrument

Andere talen Abattis Bioceuticals Corp. Canadian Securities Exchange

Aandelen

ATT

CA00258G1037

Andere talen

Zoeken op
Resultaten bekijken
Krijg toegang tot al het nieuws: wees als eerste op de hoogte en reageer voordat de beurs dat doet!
Gratis inschrijven
Abattis Bioceuticals Corp. Reports Earnings Results for the Full Year Ended September 30, 2019
Abattis Bioceuticals Corp. Announces Board Changes
Abattis Bioceuticals Corp. (OTCPK:ATTB.F) cancelled the acquisition of NutriVida Corp.
Abattis Bioceuticals Corp. Reports Earnings Results for the Third Quarter Ended June 30, 2019
Abattis Bioceuticals Corp.'s Equity Buyback announced on August 7, 2018, has expired.
Abattis Bioceuticals Corp. Reports Earnings Results for the Full Year Ended September 30, 2018
Abattis Bioceuticals Corp. (OTCPK:ATTB.F) cancelled the acquisition of Winston Resources Inc..
Abattis Bioceuticals Corp. (OTCPK:ATTB.F) completed the acquisition of Pro Natura BV from The Catalyst Capital Group Inc.
Abattis Bioceuticals : Announces Acquisition of European Nutraceutical Company and Provides Corporate Updates
Abattis Bioceuticals Corp. Announces Management Changes
Abattis Bioceuticals Corp. (OTCPK:ATTB.F) agreed to acquire Pro Natura BV from The Catalyst Capital Group Inc. for €15.7 million.
Abattis Bioceuticals Corp. Announces Resignations in Board
British Columbia Securities Commission Removes Temporary Order on Abattis Bioceuticals Corp
Abattis Bioceuticals Corp Announces Launch of Its New Website and Provide an Operational Update
Abattis Bioceuticals Corp. (OTCPK:ATTB.F) signed a letter of intent to acquire NutriVida Corp. for CAD 15 million.
Abattis Bioceuticals Corp Signs a Distribution Agreement with Shefield &Sons Tobacconists Inc. to Sell the Abattis Vaporizer Line in all Shefield &Sons Stores Across Canada
Abattis Bioceuticals Corp. (OTCPK:ATTB.F) acquired Select Strains Inc. for $3.5 million.
Abattis Bioceuticals Corp. Announces Executive Changes
Abattis Intends To Seek Acquisitions
Abattis Bioceuticals Corp. Announces Board Changes
Geen resultaten voor deze zoekopdracht
Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Filters

Zoeken op

Datum van publicatie

Sinds de

Tot

  1. Beurs
  2. Aandelen
  3. Koers ATTBF
  4. Koers ATT
  5. Nieuws Abattis Bioceuticals Corp.
  6. Andere talen